EGFR and non-small cell lung carcinoma: We further demonstrated the combining YD, an AXL degrader, and EGFR-TKI resulted in overcoming resistance in EGFR-TKIs resistant NSCLC cells also delaying the emergence of resistance in EGFR-TKI sensitive NSCLC cells using tumor xenograft, and PDX model.